Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Deficit)
Beginning balance (in shares) at Dec. 31, 2019   36,878,000    
Beginning balance at Dec. 31, 2019 $ 52,809 $ 37 $ 60,742 $ (7,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Sale of common stock, net of fees (in shares)   14,375,000    
Sale of common stock, net of fees 207,134 $ 14 207,120  
Common stock issued upon warrant exercise (in shares)   1,370,000    
Common stock issued upon warrant exercise 3,842 $ 1 3,841  
Common stock issued upon cashless exercise of warrants (in shares)   918,000    
Common stock issued upon cashless exercise of warrants 0 $ 1 (1)  
Common stock issued upon exercise of options (in shares)   71,000    
Common stock issued upon exercise of options 230   230  
Common stock issued upon cashless exercise of options (in shares)   694,000    
Common stock issued upon cashless exercise of options 0 $ 1 (1)  
Common stock issued in connection with business combinations (in shares)   1,730,000    
Common stock issued in connection with business combinations 39,147 $ 2 39,145  
Common stock issued for assets (in shares)   20,000    
Common stock issued for assets 136   136  
Common stock issued for services (in shares)   50,000    
Common stock issued for services 0      
Common stock issued for accrued payroll (in shares)   325,000    
Common stock issued for accrued payroll 717   717  
Common stock issued for accrued share-based compensation (in shares)   729,000    
Common stock issued for accrued share-based compensation 3,798 $ 1 3,797  
Share based compensation, net of shares withheld for employee tax liability (in shares)   (8,000)    
Share based compensation, net of shares withheld for employee tax liability 3,856   3,856  
Net income (loss) 5,328     5,328
Ending balance (in shares) at Dec. 31, 2020   57,152,000    
Ending balance at Dec. 31, 2020 316,997 $ 57 319,582 (2,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   256,000    
Common stock issued upon warrant exercise 335   335  
Common stock issued upon cashless exercise of warrants (in shares)   657,000    
Common stock issued upon cashless exercise of warrants 0 $ 1 (1)  
Common stock issued upon exercise of options (in shares)   469,000    
Common stock issued upon exercise of options 1,758 $ 1 1,757  
Common stock issued upon cashless exercise of options (in shares)   325,000    
Common stock issued in connection with business combinations (in shares)   807,000    
Common stock issued in connection with business combinations 37,272 $ 1 37,271  
Common stock issued in connection with purchase of intangible assets (in shares)   4,000    
Common stock issued in connection with purchase of intangible assets 168   168  
Common stock issued for services (in shares)   145,000    
Common stock issued for services 717   717  
Common stock issued for accrued share-based compensation (in shares)   204,000    
Common stock redeemed in litigation settlement (in shares)   (90,000)    
Share based compensation, net of shares withheld for employee tax liability 1,258   1,258  
Net income (loss) $ 12,786     12,786
Ending balance (in shares) at Dec. 31, 2021 59,928,564 59,929,000    
Ending balance at Dec. 31, 2021 $ 371,291 $ 60 361,087 10,144
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon cashless exercise of warrants (in shares)   14,000    
Common stock issued upon cashless exercise of warrants 0      
Common stock issued upon exercise of options (in shares)   9,000    
Common stock issued upon exercise of options 33   33  
Common stock issued upon cashless exercise of options (in shares)   20,000    
Common stock issued in connection with business combinations (in shares)   700,000    
Common stock issued in connection with business combinations 5,711 $ 1 5,710  
Adjustment for prior period acquisition 39   39  
Common stock issued for accrued share-based compensation (in shares)   339,000    
Common stock issued for accrued share-based compensation 4,514   4,514  
Common stock redemption $ (1,618)   (1,618)  
Common stock issued in connection with asset acquisition (in shares) 50,000      
Common stock issued in connection with asset acquisition $ 173      
Net income (loss) $ (163,747)     (163,747)
Ending balance (in shares) at Dec. 31, 2022 61,010,155 61,061,000    
Ending balance at Dec. 31, 2022 $ 216,396 $ 61 $ 369,938 $ (153,603)